Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir

Clinical trial NCT05169580 · COMPLETED

Trial details

NCT number: NCT05169580
Sponsor: Fulcrum Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anemia

Start date: 2021-12-13
Primary completion: 2026-01-20
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.